136 related articles for article (PubMed ID: 24148752)
1. Comparison of baseline quality of life measures between renal cell carcinoma patients undergoing partial versus radical nephrectomy.
Arnold ML; Thiel DD; Diehl N; Wu KJ; Ames S; Parker AS
BMC Urol; 2013 Oct; 13():52. PubMed ID: 24148752
[TBL] [Abstract][Full Text] [Related]
2. Comparison of patient-reported quality of life outcome questionnaire response rates between patients treated surgically for renal cell carcinoma and prostate carcinoma.
Thiel DD; Davidiuk AJ; Broderick GA; Arnold M; Diehl N; Tavlarides A; Custer K; Parker AS
BMC Urol; 2015 Jul; 15():58. PubMed ID: 26126615
[TBL] [Abstract][Full Text] [Related]
3. Quality of life after surgery for localized renal cell carcinoma: comparison between radical nephrectomy and nephron-sparing surgery.
Poulakis V; Witzsch U; de Vries R; Moeckel M; Becht E
Urology; 2003 Nov; 62(5):814-20. PubMed ID: 14624900
[TBL] [Abstract][Full Text] [Related]
4. Psycho-social well-being and general health status after surgical treatment for localized renal cell carcinoma.
Ficarra V; Novella G; Sarti A; Novara G; Galfano A; Cavalleri S; Artibani W
Int Urol Nephrol; 2002; 34(4):441-6. PubMed ID: 14577481
[TBL] [Abstract][Full Text] [Related]
5. Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma.
Gratzke C; Seitz M; Bayrle F; Schlenker B; Bastian PJ; Haseke N; Bader M; Tilki D; Roosen A; Karl A; Reich O; Khoder WY; Wyler S; Stief CG; Staehler M; Bachmann A
BJU Int; 2009 Aug; 104(4):470-5. PubMed ID: 19239445
[TBL] [Abstract][Full Text] [Related]
6. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
[TBL] [Abstract][Full Text] [Related]
7. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.
Lau WK; Blute ML; Weaver AL; Torres VE; Zincke H
Mayo Clin Proc; 2000 Dec; 75(12):1236-42. PubMed ID: 11126830
[TBL] [Abstract][Full Text] [Related]
8. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
[TBL] [Abstract][Full Text] [Related]
9. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
Daugherty M; Bratslavsky G
Urol Oncol; 2014 Jul; 32(5):549-54. PubMed ID: 24495447
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma.
Hutterer GC; Patard JJ; Colombel M; Belldegrun AS; Pfister C; Guille F; Artibani W; Montorsi F; Pantuck AJ; Karakiewicz PI
Cancer; 2007 Dec; 110(11):2428-33. PubMed ID: 17941033
[TBL] [Abstract][Full Text] [Related]
11. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
[TBL] [Abstract][Full Text] [Related]
12. Age distribution for partial and radical nephrectomy: whose nephrons are being spared?
von Klot C; Herrmann TR; Wegener G; Kuczyk MA; Hupe MC; Akkoyun M; Peters I; Kramer MW; Merseburger AS
Adv Ther; 2013 Oct; 30(10):924-32. PubMed ID: 24155056
[TBL] [Abstract][Full Text] [Related]
13. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Marechal JM; Klotz L; Skinner E; Keane T; Claessens I; Sylvester R; ; ; ;
Eur Urol; 2007 Jun; 51(6):1606-15. PubMed ID: 17140723
[TBL] [Abstract][Full Text] [Related]
14. Comparison of long-term results after nephron-sparing surgery and radical nephrectomy in treating 4- to 7-cm renal cell carcinoma.
Milonas D; Skulčius G; Baltrimavičius R; Auškalnis S; Kinčius M; Matjošaitis A; Gudinavičienė I; Smailytė G; Jievaltas M
Medicina (Kaunas); 2013; 49(5):223-8. PubMed ID: 24247918
[TBL] [Abstract][Full Text] [Related]
15. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
Crépel M; Jeldres C; Perrotte P; Capitanio U; Isbarn H; Shariat SF; Liberman D; Sun M; Lughezzani G; Arjane P; Widmer H; Graefen M; Montorsi F; Patard JJ; Karakiewicz PI
Urology; 2010 Feb; 75(2):271-5. PubMed ID: 19962740
[TBL] [Abstract][Full Text] [Related]
16. Factors predicting health-related quality of life recovery in patients undergoing surgical treatment for renal tumors: prospective evaluation using the RAND SF-36 Health Survey.
Novara G; Secco S; Botteri M; De Marco V; Artibani W; Ficarra V
Eur Urol; 2010 Jan; 57(1):112-20. PubMed ID: 19406562
[TBL] [Abstract][Full Text] [Related]
17. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
Margulis V; Tamboli P; Jacobsohn KM; Swanson DA; Wood CG
BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
[TBL] [Abstract][Full Text] [Related]
18. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence.
Blute M; Thibault GP; Leibovich BC; Cheville JC; Lohse CM; Zincke H
J Urol; 2003 Sep; 170(3):760-3. PubMed ID: 12913692
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: impact of the amount of remaining renal tissue.
Clark PE; Schover LR; Uzzo RG; Hafez KS; Rybicki LA; Novick AC
Urology; 2001 Feb; 57(2):252-6. PubMed ID: 11182331
[TBL] [Abstract][Full Text] [Related]
20. Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer.
MacLennan S; Imamura M; Lapitan MC; Omar MI; Lam TB; Hilvano-Cabungcal AM; Royle P; Stewart F; MacLennan G; MacLennan SJ; Dahm P; Canfield SE; McClinton S; Griffiths TR; Ljungberg B; N'Dow J; ;
Eur Urol; 2012 Dec; 62(6):1097-117. PubMed ID: 22841673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
